We are live on ! Find out more
BHMP

Bardin Hill Management Partners Portfolio holdings

AUM $80.3M
1-Year Est. Return 31.39%
This Fund
S&P 500
This Quarter Est. Return
+28.95%
1 Year Est. Return
+31.39%
3 Year Est. Return
+213.94%
5 Year Est. Return
+674.31%
10 Year Est. Return
+9,424.11%
AUM
$608M
AUM Growth
+$31.5M
Cap. Flow
-$50.2M
Cap. Flow %
-8.26%
Top 10 Hldgs %
69.21%
Holding
50
New
17
Increased
9
Reduced
2
Closed
17

Sector Composition

Rank Sector Weight
1 Healthcare 22.79%
2 Energy 11.51%
3 Industrials 9.64%
4 Consumer Discretionary 8.29%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WCG
1
DELISTED
Wellcare Health Plans, Inc.
WCG
$75.7M 12.46%
229,373
+56,459
+33% +$16.9M
AGN
2
DELISTED
Allergan plc
AGN
$66.6M 10.96%
348,434
+98,952
+40% +$17.9M
NEXT icon
3
NextDecade
NEXT
$1.85B
$58M 9.54%
9,449,846
CZR
4
DELISTED
Caesars Entertainment Corporation
CZR
$42.7M 7.02%
3,137,263
-98,467
-3% -$1.25M
ZAYO
5
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$37.4M 6.15%
1,080,015
+111,765
+12% +$3.83M
MDCO
6
DELISTED
Medicines Co
MDCO
$35.3M 5.81%
+415,862
New +$27.7M
ADSW
7
DELISTED
Advanced Disposal Services Inc
ADSW
$28.2M 4.63%
856,904
+296,699
+53% +$9.73M
TSG
8
DELISTED
The Stars Group Inc.
TSG
$26.9M 4.43%
+1,032,532
New +$23.1M
EE
9
DELISTED
El Paso Electric Company
EE
$25.8M 4.24%
379,354
+57,767
+18% +$3.89M
RTX icon
10
RTX Corp
RTX
$287B
$24.1M 3.97%
256,121
+50,360
+24% +$4.57M
BOLD
11
DELISTED
Audentes Therapeutics, Inc
BOLD
$20.3M 3.34%
+339,111
New +$12.7M
TIF
12
DELISTED
Tiffany & Co.
TIF
$19.6M 3.23%
+146,831
New +$17.4M
RARX
13
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$18.4M 3.02%
+391,758
New +$17.3M
GEN icon
14
CALL
Gen Digital
GEN
$15.6B
$13.5M 2.22%
+6,566
New +$160K
QGEN icon
15
Qiagen
QGEN
$8.53B
$12.8M 2.11%
+357,292
New +$13.3M
WMGI
16
DELISTED
Wright Medical Group Inc
WMGI
$12.5M 2.06%
+411,713
New +$10.8M
TGE
17
DELISTED
Tallgrass Energy, LP Class A Shares
TGE
$12M 1.97%
541,519
+427,342
+374% +$8.2M
TECD
18
DELISTED
Tech Data Corp
TECD
$9.29M 1.53%
+64,663
New +$8.32M
LOGM
19
DELISTED
LogMein, Inc.
LOGM
$9.23M 1.52%
+107,678
New +$7.99M
GEN icon
20
Gen Digital
GEN
$15.6B
$8.57M 1.41%
335,835
-338,268
-50% -$8.27M
INXN
21
DELISTED
Interxion Holding N.V.
INXN
$7.79M 1.28%
+92,961
New +$7.76M
ARQL
22
DELISTED
Arqule Inc
ARQL
$7.78M 1.28%
+389,635
New +$4.52M
WBC
23
DELISTED
WABCO HOLDINGS INC.
WBC
$7.77M 1.28%
57,320
+12,028
+27% +$1.62M
CCO icon
24
Clear Channel Outdoor Holdings
CCO
$1.23B
$6.67M 1.1%
2,332,687
+292,000
+14% +$739K
AXE
25
DELISTED
Anixter International Inc
AXE
$6.31M 1.04%
+68,498
New +$5.55M

Similar funds

Bardin Hill Management Partners's Q4 2019 Portfolio in Review

As of Q4 2019, Bardin Hill Management Partners held 50 positions worth $608M, up 5.5% from $577M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Bardin Hill Management Partners withdrew a net $50.2M in Q4 2019, closing 17 positions and reducing 2 holdings. Its most notable exit was Celgene Corp, an estimated $59.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 19% a quarter earlier, followed by Energy and Industrials.

Against the trend, Bardin Hill Management Partners opened a new position in Medicines Co worth $35.3M.

  • Bardin Hill Management Partners's largest Q4 2019 buy was Medicines Co: 415,862 shares worth $35.3M.
  • Bardin Hill Management Partners added most to Allergan plc in Q4 2019, an estimated $17.9M increase.
  • Bardin Hill Management Partners's biggest Q4 2019 reduction was Gen Digital, cutting an estimated $8.27M.
  • Bardin Hill Management Partners fully exited Celgene Corp in Q4 2019, selling an estimated $59.3M.
  • Bardin Hill Management Partners's ten largest holdings make up 69% of its $608M portfolio in Q4 2019.
  • Bardin Hill Management Partners opened 17 new positions and closed 17 in Q4 2019.
  • Bardin Hill Management Partners's portfolio value rose 5.5% quarter-over-quarter to $608M.

Based on Bardin Hill Management Partners's 13F filing for Q4 2019, filed 14 Feb 2020.